Machine Learning

In a radical pivot, diagnostics firm OpGen has become CapForce, an AI-powered investment bank targeting a $10B niche. Can it trade microbes for money?

Biotech firm NurExone showcases its CNS injury platform at key conferences, but the exit of its US subsidiary's CEO casts a shadow on growth plans.

Facing delisting for being a 'public shell,' XTL Biopharma plans an appeal while its new acquisition and valuable IP hang in the balance.

The biotech firm's stock surged after announcing a massive share repurchase, a bold move balancing shareholder value with its high-stakes R&D pipeline.

The clean-label whey brand launches an AI-generated world to fight industry misinformation, blending tech innovation with a mission for authentic nutrition.

The Michael J. Fox Foundation adds private equity and AI venture capital leaders to its board, signaling a strategic push to accelerate a cure for Parkinson's.

As Cipla rolls out its affordable Liraglutide injection, the battle for the multi-billion dollar GLP-1 market intensifies, promising greater access for patients.

A new AI system testing millions of spins finds nearly 1 in 5 online slots have payout rates that significantly differ from what's advertised.

Aristocrat sweeps the EKG Slot Awards, securing its 8th straight top supplier win and proving its mastery of both casino floors and the digital realm.

A new partnership brings a high-speed digital pathology scanner to the U.S. for the first time, promising to revolutionize diagnostic speed and accuracy.

At MWC 2026, DeepSig and partners NVIDIA & PCTEL showcase AI-native solutions poised to transform mobile networks and tactical spectrum intelligence.

With a massive $1.7B war chest from government and industry, can Japan's Rapidus truly race against TSMC and Samsung to mass-produce 2nm chips by 2027?

A new venture is leveraging advanced extraction tech and a novel business model to develop lithium in the Americas, aiming to secure vital supply chains.

A major financial hub deployed new AI to combat a 350% surge in deepfake attacks, preventing massive fraud without slowing down digital growth.

Born from a Novartis mega-deal, Atrium Therapeutics aims its novel RNA platform at rare, untreatable genetic heart diseases. Will its strategy succeed?

The AI logistics firm's new Texas office signals a major shift, placing advanced software development at the heart of the U.S. military's operational core.

Deal activity is surging in private markets, but a new era of selective investment and AI-driven opportunities is forcing investors to adapt. Here's the outlook.

Xiaomi overtakes Apple in the wearable market for the first time since 2020, signaling a major industry shift from device sales to AI-driven ecosystems.

A new strategic partnership puts AMC Robotics' advanced sorting robot to the test, signaling a pivotal shift from lab development to real-world logistics.

Trump Media plans a complex deal to spin off Truth Social after its fusion energy merger, aiming to create two distinct publicly traded companies.